EAST RUTHERFORD, N.J., Feb. 1, 2013 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) announced that fourth quarter 2012 financial results will be released on Wednesday, February 6, 2013 after the market closes.
The Company will host a conference call to discuss the financial results.
Fourth Quarter 2012 Earnings Conference Call
Thursday, February 7, 2013 at 8:30 a.m. Eastern Time
1-800-723-6604 for U.S.
1-785-830-7977 for International
1-888-203-1112 for U.S.
1-719-457-0820 for International
Available through Thursday, February 14, 2013
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.
SOURCE Cambrex Corporation